Factors associated with multidrug-resistant Pseudomonas aeruginosa infection: a hospital-based case-control study

Article Sidebar

PDF
Published: Aug 15, 2021
Keywords:
Multidrug resistance Pseudomonas aeruginosa Mechanical ventilator Endotracheal tube

Main Article Content

Peechanika Chopjitt
Faculty of Public Health, Kasetsart University Chalermphrakiat, Sakon Nakhon Campus, Sakon Nakhon, Thailand.
Nuntiput Putthanachote
Department of Clinical Microbiology , Roi Et Hospital, Roi Et, Thailand.
Narongchai Sangsa
Department of Medicine, Roi Et Hospital, Roi Et, Thailand.
Phatsaraporn Sirisa
Department of Infectious Control, Roi Et Hospital, Roi Et, Thailand.
Sermchart Chinnakarnsawas
Department of Medicine, Roi Et Hospital, Roi Et, Thailand.
Chakrit Kankang
Research office, Roi Et Hospital, Roi Et, Thailand.
Benjawan Comhangpol
Department of Infectious Control, Roi Et Hospital, Roi Et, Thailand.
Pakinee Lengwehasatit
Department of Pharmaceutical, Roi Et Hospital, Roi Et, Thailand.
Pisacha Kasemsup
Department of Pharmaceutical, Roi Et Hospital, Roi Et, Thailand.
Wongklang Gudwongsa
Laobuaban Health Promoting Hospital, Mahasarakham, Thailand.
Pongdech Sarakarn
Department of Epidemiology and Biostatistics Faculty of Public Health, Khon Kaen University , Khon Kaen, Thailand.

Abstract

This study aimed to investigate the factors associated with multidrugresistant Pseudomonas aeruginosa (MDR-PA) infection. The study was a hospital-based case-control study. Data were collected from medical records of patients with MDR-PA infection (110 cases) and without MDR-PA infection (110 controls) at the Roi Et Hospital between January 1, 2015 and December 31, 2017. Data analysis used statistics, univariable analysis, and multiple logistic regressions. Statistical significance was set at p-value < 0.05. Most of the 110 cases with MDR-PA infection were male (51.82%) and the mean age was 61.82 ± 15.67 years, while most of the 110 controls were male (56.36%) and the mean age was 55.01 ± 16.09 years. The multivariable analysis revealed that patients aged over 60 years (ORAdj = 2.06, 95%CI = 1.14-3.71), admitted for more than 7 days (ORAdj = 2.43, 95%CI = 1.28-4.60), underwent procedures involving an endotracheal tube (ORAdj = 2.61, 95%CI = 1.42-4.80) and a mechanical ventilator (ORAdj = 3.14, 95%CI = 1.67-5.88). Therefore, the risk factors for MDR-PA infection were patients who were admitted for more than 7 days, who underwent procedures involving an endotracheal tube and a mechanical ventilator.

Article Details

How to Cite
1.
Chopjitt P, Putthanachote N, Sangsa N, Sirisa P, Chinnakarnsawas S, Kankang C, Comhangpol B, Lengwehasatit P, Kasemsup P, Gudwongsa W, Sarakarn P. Factors associated with multidrug-resistant Pseudomonas aeruginosa infection: a hospital-based case-control study. Arch AHS [Internet]. 2021 Aug. 15 [cited 2024 Nov. 21];33(2):48-55. Available from: https://he01.tci-thaijo.org/index.php/ams/article/view/219028
Issue
Vol. 33 No. 2 (2021): May - August
Section
Original article
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

Su H, Ye Q, Wan Q, Zhou J. Predictors of mortality in abdominal organ transplant recipients with Pseudomonas aeruginosa infections. Ann Transplant 2016; 21: 86-93.

Peña C, Cabot G, Gómez-Zorrilla S, Zamorano L, Ocampo-Sosa A, Murillas J, et al. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections. Clin Infect Dis Off Publ Infect Dis Soc Am 2015; 60(4): 539-48.

Morales E, Cots F, Sala M, Comas M, Belvis F, Riu M, et al. Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition. BMC Health Serv Res 2012; 12: 122.

Peng Y, Bi J, Shi J, Li Y, Ye X, Chen X, et al. Multidrug-resistant Pseudomonas aeruginosa infections pose growing threat to health care-associated infection control in the hospitals of Southern China: a case-control surveillance study. Am J Infect Control 2014; 42(12): 1308-11.

Gallego M, Pomares X, Espasa M, Castañer E, Solé M, Suárez D, et al. Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors. BMC Pulm Med 2014; 14: 103.

Tumbarello M, Repetto E, Trecarichi EM, Bernardini C, De Pascale G, Parisini A, et al. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. Epidemiol Infect 2011; 139(11): 1740-9.

Danchaivijitr S, Judaeng T, Sripalakij S, Naksawas K, Plipat T. Prevalence of nosocomial infection in Thailand 2006. J Med Assoc Thail Chotmaihet Thangphaet 2007; 90(8):1524-9.

Dejsirilert S, Suankratay C, Trakulsomboon S, Thongmali O, Sawanpanyalert P, Aswapokee N, et al. National antimicrobial resistance surveillance, Thailand (NARST) data among clinical isolates of Pseudomonas aeruginosa in Thailand from 2000 to 2005. J Med Assoc Thail Chotmaihet Thangphaet 2009; 92: S68-75.

Nseir S, Blazejewski C, Lubret R, Wallet F, Courcol R, Durocher A. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 2011; 17(8): 1201-8.

Aloush V, Navon-Venezia S, Seigman-Igra Y, Cabili S, Carmeli Y. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother 2006; 50(1): 43-8.

Micek ST, Wunderink RG, Kollef MH, Chen C, Rello J, Chastre J, et al. An international multicenter retrospective study of Pseudomonas aeruginosanosocomial pneumonia: impact of multidrug resistance. Crit Care Lond Engl 2015; 19(1): 219.

Yang MA, Lee J, Choi EH, Lee HJ. Pseudomonas aeruginosabacteremia in children over ten consecutive years: analysis of clinical characteristics, risk factors of multi-drug resistance and clinical outcomes. J Korean Med Sci 2011; 26(5): 612-8.

Gómez-Zorrilla S, Camoez M, Tubau F, Periche E, Cañizares R, Dominguez MA, et al. Antibiotic pressure is a major risk factor for rectal colonization by multidrug-resistant Pseudomonas aeruginosain critically ill patients. Antimicrob Agents Chemother 2014; 58(10): 5863-70.

Peña C, Gómez-Zorrilla S, Oriol I, Tubau F, Dominguez MA, Pujol M, et al. Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 2013; 32(3): 413-20.

Defez C, Fabbro-Peray P, Bouziges N, Gouby A, Mahamat A, Daurès JP, et al. Risk factors for multidrug-resistant Pseudomonas aeruginosanosocomial infection. J Hosp Infect 2004; 57(3): 209-16.